11/21/2025
Editorial: Microaxial flow pump therapy may be most beneficial for myocardial infarction patients with cardiogenic shock experiencing severe hypotension despite vasopressor use. https://ja.ma/48aeaqk
JAMA Cardiology is a member of the JAMA Network, a consortium of peer-reviewed publications
330 N Wabash Avenue
Chicago, IL
60611
Be the first to know and let us send you an email when JAMA Cardiology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.